Aging and comorbidities: a hot topic at the #MSParis2016 conference
Comorbidities (when someone is living with more than one condition) are common in MS and can affect people at the onset of their…
2017 revisions to MS diagnostic criteria presented at #MSParis2017 conference
The McDonald criteria for MS was first established in 2001 by neurologist Ian McDonald and his team of researcher to diagnose individuals with…
Taking the road less traveled to get my life back: Cathy’s BMT trial journey
Guest post by Cathy Nabuurs, Canadian Bone Marrow Transplantation trial participant The opportunity to become a participant in the Canadian Bone Marrow Transplantation…
Researchers at #MSParis2017 talk about the factors regulating the Blood Brain Barrier in MS
The blood-brain barrier (BBB) was highlighted in a session at the #MSParis2017 conference where researchers presented their recent findings on the relationship between…
Project Jessie
Guest post by Jessica Winger, diagnosed with MS in 2015 I was diagnosed with relapsing-remitting multiple sclerosis in November 2015. Before I was…
Bonjour Paris! World’s leading researchers and clinicians gather in Paris for largest MS conference
The MS Society of Canada’s research team has arrived in the exciting city of Paris, France to attend the 7th Joint ACTRIMS/ECTRIMS meeting…
On the persistence of art and friendship
Lelainia has been an artist all her life. In 2007, when she lost feeling in her arms due to damage in her spinal…
Diet and MS: What does research tell us about supplements?
A question I frequently receive is: “Are there supplements I can take to manage my MS?” MS impacts the day-to-day lives of those…
The ins and outs of clinical trials
So what does it cost to run a clinical trial, anyway? Performing a clinical trial requires a great deal of resources. Namely, time,…
What is MS?
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.